A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, And Pharmacodynamics of Bitopertin (RO4917838) in Adults with Non Transfusion Dependent β-Thalassemia.

Registry ID

EUCTR2016-004799-23

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

F. HOFFMANN - LA ROCHE LTD.

Start date

2017-09-04

Last update

2026-08-16

Conditions

• β-Thalassemia

Summary

• To evaluate the safety and tolerability of repeated oral doses of bitopertin in patients with non-transfusion dependent (NTD) β-thalassemia • To evaluate the effects of repeated oral doses of bitopertin on change from baseline in total Hb values in patients with NTD β- thalassemia.

Locations

• , , Italy

View on source registry